Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2002Expert Opinion on Therapeutic Targets

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

View Full Paper
Ask AI
Bookmark
Share

Authors

FBFrédéric BaribaudBristol-Myers Squibb (Germany)
Robert W. Doms
Robert W. DomsThe Wistar InstituteSPStefan PöhlmannGerman Primate Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Baribaud et al. (2002) studied this question.

synapsesocial.com/papers/6a91475db68aa5977865e461https://doi.org/10.1517/14728222.6.4.423
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cutting Edge: DC-SIGN; a Related Gene, DC-SIGNR; and CD23 Form a Cluster on 19p132000 · 261 citations
  2. 2A Novel Mechanism of Carbohydrate Recognition by the C-type Lectins DC-SIGN and DC-SIGNR2001 · 502 citations
  3. 3Expression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans and Rhesus Macaques2002 · 260 citations
  4. 4Ebola haemorrhagic fever in Zaire1996 · 481 citations
  5. 5Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.1992 · 385 citations